Lipoprotein(a), apolipoprotein B and other lipid biomarkers in Asian healthcare workers. [PDF]
Loh WJ +12 more
europepmc +1 more source
Frailty and Cardiovascular Events as Determined by Body Composition: A Systematic Review
Frailty phenotypes and risk of cardiovascular disease. Sarcopenic obese phenotype is associated with increased prevalence of cardiovascular risk factors and progression of metabolic syndrome, leading to cardiovascular events and cardiovascular mortality, while the Anorexic malnourished phenotype is associated with reduced prevalence of cardiovascular ...
Ishleen Oberoi +5 more
wiley +1 more source
Exploring the role of gelsolin and high-density lipoproteins in autoimmune diseases: spotlight on rheumatoid arthritis and systemic lupus erythematosus. [PDF]
Pérez-Ocampo J, Hernandez JC.
europepmc +1 more source
Endogenous GLP‐1 and exogenous GLP‐1 RAs activate GLP‐1R‐expressing vagal afferents in the portal vein, projecting to the nucleus tractus solitarius (NTS). This input engages brainstem–hypothalamic circuits that regulate metabolic homeostasis. Hypothalamic efferent vagal output to the liver suppresses lipogenesis, enhances triglyceride export, and ...
Gabriel Amorim Moreira Alves +8 more
wiley +1 more source
Rethinking Cholesterol Management in Women: From Short-Term Risk Estimation to Lifecourse Cardiovascular Health. [PDF]
Honigberg MC.
europepmc +1 more source
Boron Neutron Capture Therapy at a Crossroads: Translational Gap and Emerging Delivery Agents
This review surveys recent advances in boron delivery agents for BNCT, emphasizing the shift from classical small molecules to multifunctional nanocarriers and theranostic systems. By integrating targeting, imaging, and therapy, next‐generation boron compounds aim to bridge the gap between (bio)chemical innovation and clinical translation.
Christoph Selg, Evamarie Hey‐Hawkins
wiley +1 more source
Metabolic profiles of captive Asian elephants (Elephas maximus) in Lao PDR and Thailand. [PDF]
López Pérez AB +7 more
europepmc +1 more source
Proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies (mAbs) lower LDL cholesterol and may influence cancer through immunomodulatory pathways. However, their effect on human cancer incidence remains unknown. We conducted a retrospective, propensity score‐matched study (Clalit Health Services, Israel, 2010–2023) comparing PCSK9 ...
Inbar Nardi Agmon +10 more
wiley +1 more source
Integrating mass spectrometry-based multi-omic signatures of extracellular vesicles: from discovery to clinical translation. [PDF]
Wijerathna-Yapa A +2 more
europepmc +1 more source
CRISPR gene editing of angiopoietin-like 3: toward one-time precision therapy for dyslipidaemia. [PDF]
Mondal A, Misra A.
europepmc +1 more source

